- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02818127
Assessment Of Total Coronary Circulation Time Using TIMI Frame Count Method (TCCT-TIMI) (TCCT-TIMI)
July 10, 2016 updated by: Vascular and Molecular Cardiology Society
Assessment Of Total Coronary Circulation Time Using TIMI Frame Count Method In Patients Undergoing Coronary Angiography
The aim of this study is to evaluate and describe the total coronary circulation time (TCCT) by using TIMI frame count method in patients performed coronary angiography.
TCCT is described as an angiographic index which is the sum of the frame count of coronary artery and venous system.
This study also evaluates the relationship between the diseases in arterial system such as coronary artery ectasia, coronary slow flow, coronary artery disease and coronary venous pathologies.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
2000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Malatya, Turkey
- Recruiting
- Private Gözde Hospital
-
Contact:
- Izzet Tandogan, MD
-
Principal Investigator:
- Izzet Tandogan, MD
-
Mersin, Turkey
- Recruiting
- Private Yenisehir Hospital
-
Contact:
- Ertan Yetkin, MD
- Phone Number: 905327136721
- Email: ertanyetkin@hotmail.com
-
Principal Investigator:
- Ertan Yetkin, MD
-
-
Kecioren
-
Ankara, Kecioren, Turkey
- Recruiting
- Gülhane Military Medical Academy
-
Contact:
- Turgay Celik, MD
- Phone Number: 905326731032
- Email: benturgay@gmail.com
-
Principal Investigator:
- Turgay Celik, MD
-
Sub-Investigator:
- Mustafa Demir, MD
-
Sub-Investigator:
- Ali Osman Yıldırım, MD
-
Sub-Investigator:
- Cengiz Öztürk, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients whom performed coronary angiography with a suspicion of coronary artery disease
Exclusion Criteria:
- History of cerebrovascular disease, chronic inflamatuar disease, malignity, chronic kidney and hepatic disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: normal coronary artery
coronary angiography will be performed by transfemoral or transradial route.
|
Coronary angiography will be performed by transfemoral or transradial approach in all patients.
In order to evaluate each coronary artery, at least four views from the left and two views from the right system will be taken.
|
Active Comparator: coronary slow flow
coronary angiography will be performed by transfemoral or transradial route.
|
Coronary angiography will be performed by transfemoral or transradial approach in all patients.
In order to evaluate each coronary artery, at least four views from the left and two views from the right system will be taken.
|
Active Comparator: coronary artery ectasia
coronary angiography will be performed by transfemoral or transradial route.
|
Coronary angiography will be performed by transfemoral or transradial approach in all patients.
In order to evaluate each coronary artery, at least four views from the left and two views from the right system will be taken.
|
Active Comparator: non-obstructive coronary artery disease
coronary angiography will be performed by transfemoral or transradial route.
|
Coronary angiography will be performed by transfemoral or transradial approach in all patients.
In order to evaluate each coronary artery, at least four views from the left and two views from the right system will be taken.
|
Active Comparator: obstructive coronary artery disease
coronary angiography will be performed by transfemoral or transradial route.
|
Coronary angiography will be performed by transfemoral or transradial approach in all patients.
In order to evaluate each coronary artery, at least four views from the left and two views from the right system will be taken.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Evaluation of total coronary circulation time by using TIMI frame count method
Time Frame: 1 day
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996 Mar 1;93(5):879-88. doi: 10.1161/01.cir.93.5.879.
- von Ludinghausen M. The venous drainage of the human myocardium. Adv Anat Embryol Cell Biol. 2003;168:I-VIII, 1-104. doi: 10.1007/978-3-642-55623-4.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2016
Primary Completion (Anticipated)
July 1, 2017
Study Completion (Anticipated)
July 1, 2017
Study Registration Dates
First Submitted
June 27, 2016
First Submitted That Met QC Criteria
June 27, 2016
First Posted (Estimate)
June 29, 2016
Study Record Updates
Last Update Posted (Estimate)
July 12, 2016
Last Update Submitted That Met QC Criteria
July 10, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Vasmol002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on coronary angiography
-
Institute for Clinical Evaluative SciencesCompleted
-
University Hospital of PatrasCompletedCoronary Artery Bypass SurgeryGreece
-
St. Olavs HospitalNorwegian University of Science and Technology; Helse Nord-Trøndelag HF; Alesund... and other collaboratorsRecruitingNon-ST Elevated Myocardial InfarctionNorway
-
Hospital San Carlos, MadridHospital General Universitario Gregorio Marañon; Hospital Clinic of Barcelona; Germans Trias i Pujol Hospital and other collaboratorsCompleted
-
Chinese Academy of Medical Sciences, Fuwai HospitalUnknownNon-ST Elevation Myocardial InfarctionChina
-
Antwerp Cardiovascular Institute MiddelheimCompletedCoronary Artery DiseaseBelgium
-
University Hospital Schleswig-HolsteinDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)CompletedOut-of-hospital Cardiac ArrestGermany
-
Assiut UniversityCompleted
-
General Hospital of Chinese Armed Police ForcesCompletedCoronary Artery DiseaseChina
-
Rennes University HospitalCompleted